The Journal of Organic Chemistry
Article
for 13 h. The reaction mixture was diluted with diethyl ether, washed
with satd NH4Cl aq, and dried over Na2SO4. The solvent was removed
in vacuo, and the residue was purified by silica gel column
chromatography (ethyl acetate/hexane = 1:10). The product 1f was
obtained as a colorless oil (730 mg, 50%): 1H NMR (300 MHz,
CDCl3) 4.94 (s, 1 H), 4.81(m, 1 H), 2.43(m, 1 H), 2.08 (m, 1 H),
1.77 (m, 1 H), 1.63 (m, 2 H), 1.58−0.87 (m, 10 H); 13C NMR
(150 MHz, CDCl3) 144.0, 111.3, 61.4, 43.7, 33.6, 31.9, 20.5,
18.7, 14.1; IR (neat) 2959, 2931, 2811, 1644, 1455, 1376, 1236,
1084, 882 cm−1; HR-MS (EI+) calcd for C9H16N ([M − H]+) 138.1283,
found 138.1284.
Preparation of Aziridine 1g. To the solution of 1,2-
dibromobutan-3-one21 (3.4 g, 15 mmol) in THF (50 mL) was
added cyclohexylamine (1.9 mL, 16.5 mmol) at 0 °C. After 5 min,
DBU (4.5 mL, 30 mmol) was added, and the mixture was stirred at
ambient temperature overnight. The salt was filtered off and washed
with diethyl ether. The solvent was removed in vacuo, and the crude
product was purified by silica gel column chromatography (ethyl
acetate/hexane = 1:5) to afford 2-acetyl-1-cyclohexylaziridine (1.68 g,
66%) as a pale brown oil: 1H NMR (600 MHz, CDCl3) 2.03 (m, 1 H),
2.01 (s, 3 H), 1.73 (m, 4 H), 1.61 (d, J = 6.8 Hz, 1 H), 1.54 (m, 1 H),
1.32−1.40 (m, 2 H), 1.12−1.20 (m, 4 H); 13C NMR (125 MHz,
CDCl3) 207.8, 68.7, 44.2, 33.8, 32.5, 32.4, 26.0, 25.2, 24.51, 24.45; IR
(neat) 3047, 2978, 2931, 2854, 1705, 1450, 1358, 1257, 1219, 1165,
1088, 1034, 980 cm−1; HR-MS (EI) calcd for C10H17NO (M+)
167.1310, found 167.1306.
To a mixture of methyltriphenylphosphonium bromide (5.4 g, 15.1
mmol) in THF (50 mL) was added n-BuLi (1.6 M in hexane, 9.1 mL,
15.1 mmol) at 0 °C. To the solution was added 2-acetyl-1-
cyclohexylaziridine (1.68 g, 10.0 mmol) in THF (10 mL), and the
mixture was stirred for 5 h at room temperature. The solution was
diluted with diethyl ether, washed with satd NH4Cl aq, and dried over
Na2SO4. The solvent was removed in vacuo, and the crude product
was purified by silica gel column chromatography (ethyl acetate/
hexane = 1:10) to afford 1g as a colorless oil (1.31 g, 79%): 1H NMR
(300 MHz, CDCl3) 4.91 (m, 1 H), 4.80 (m, 1 H), 1.81−1.06 (m, 17
H); 13C NMR (75 MHz, CDCl3) 144.1, 111.2, 69.5, 42.4, 32.9, 32.23,
32.18, 26.1, 24.82, 24.79, 19.3; IR (neat) 2972, 2928, 2854, 1643,
1450, 1368, 1226, 1167, 881, 829 cm−1; HR-MS (EI) calcd for
C11H19N (M+) 165.1517, found 165.1513.
General Procedure for the Cycloaddition of Vinylaziridines
and Sulfonyl Isocyanates. To a solution of sulfonyl isocyanate
(0.5 mmol) in CH2Cl2 (9 mL) was added vinylaziridine (0.5 mmol) in
CH2Cl2 (1 mL) and the solution stirred at the designated temperature.
The progress of the reaction was monitored by TLC and/or GC−MS.
After the consumption of vinylaziridine, the solvent was removed in
vacuo, and the residue was purified by silica gel column
chromatography (hexane/ethyl acetate) to give the product.
3a: colorless solid; mp 227.5−231.2 °C; 1H NMR (300 MHz,
CDCl3) 7.98−7.20 (m, 9 H), 5.71 (m, 1 H), 5.66 (m, 1 H), 4.54 (s,
2 H), 4.09 (s, 2 H), 3.89 (s, 2 H), 2.42 (s, 3 H); 13C NMR (150 MHz,
CDCl3) 157.7, 144.1, 136.0, 135.8, 129.3, 128.71, 128.69, 127.70,
127.68, 126.1, 124.9, 52.6, 46.9, 45.5, 21.6; IR (KBr) 3035, 1698, 1472,
1455, 1431, 1348, 1239, 1159, 1095, 876, 819, 735, 666, 589, 539
cm−1. Anal. Calcd for C19H20N2O3S: C, 64.02; H, 5.66; N, 7.86.
Found: C, 63.84; H, 5.73; N, 7.82.
542 cm−1. Anal. Calcd for C20H22N2O3S: C, 64.84; H, 5.99; N, 7.56.
Found: C, 64.55; H, 5.99; N, 7.44.
3d: colorless solid; mp 122.0−123.5 °C; 1H NMR (300 MHz,
CDCl3) 7.35−7.22 (m, 5 H), 5.47 (m, 1 H), 4.55 (s, 2 H), 4.02 (m, 2
H), 3.80 (m, 2 H), 3.27 (m, 3 H), 1.67 (d, J = 1.1 Hz, 3 H); 13C NMR
(75 MHz, CDCl3) 158.0, 135.9, 133.8, 128.8, 127.8, 127.7, 119.5, 52.4,
50.1, 45.3, 39.7, 21.0; IR (KBr) 3005, 2925, 1681, 1605, 1476, 1455,
1424, 1335, 1262, 1149, 1109, 1062, 1003, 963, 929, 795, 773, 729,
696, 517 cm−1. Anal. Calcd for C14H18N2O3S: C, 57.12; H, 6.16; N,
9.52. Found: C, 57.18, H, 6.35, N, 9.35.
1
3e: colorless amorphous; H NMR (300 MHz, CDCl3) 8.02−7.19
(m, 14 H), 5.82 (m, 1 H), 4.58 (s, 2 H), 4.39 (d, J = 2.1 Hz, 2 H), 4.04
(m, 2 H), 2.42 (s, 3 H); 13C NMR (75 MHz, CDCl3) 157.6, 144.2,
139.1, 138.0, 136.1, 135.9, 129.4, 128.8, 127.77, 128.76, 128.6, 128.2,
127.8, 126.2, 122.6, 52.5, 49.2, 45.9, 21.6; IR (neat) 3735, 3648, 1698,
1472, 1351, 1228, 1163, 1099, 741, 698, 659, 598, 574 cm−1. Anal.
Calcd for C25H24N2O3S: C, 69.42; H, 5.59; N, 6.48. Found: C, 69.17;
H, 5.89; N, 6.34.
3f: colorless solid; mp 131−132.3 °C; 1H NMR (300 MHz, CDCl3)
7.37−7.20 (m, 10 H), 5.85 (tt, J = 5.5, 1.7 Hz, 1 H), 4.62 (s, 2 H), 4.50
(q, J = 2.1 Hz, 2 H), 4.02 (dt, J = 5.5, 2.1 Hz, 2 H), 3.32 (s, 3 H); 13C
NMR (75 MHz, CDCl3) 187.1, 138.8, 137.8, 135.9, 128.8, 128.7,
128.4, 127.9, 127.8, 126.2, 122.4, 52.6, 49.0, 46.0, 40.0; IR (KBr) 3026,
2924, 2360, 1698, 1468, 1335, 1159, 966, 765, 696, 497 cm−1; HR-MS
(ESI) calcd for C19H20N2O3S ([M + Na]+) 379.1087, found 379.1099.
3g: colorless solid; mp 127.8−130.0 °C; 1H NMR (300 MHz,
CDCl3) 7.96 (d, J = 8.4 Hz, 2H), 7.34−7.21 (m, 7 H), 4.89 (t, J = 6.0
Hz, 1 H), 4.53 (s, 2 H), 3.86 (d, J = 1.5 Hz, 2 H), 3.82 (d, 6.0 Hz, 2
H), 2.42 (s, 3 H), 0.86 (s, 9 H), 0.06 (s, 6 H); 13C NMR (150 MHz,
CDCl3) 156.9, 149.5, 144.1, 136.1, 135.8, 129.4, 128.73, 128.70, 127.8,
127.7, 101.6, 52.3, 48.8, 43.3, 25.5, 21.6, 17.9, −4.7; IR (KBr) 3648,
2929, 1696, 1464, 1350, 1244, 1210, 1166, 1099, 884, 830, 733, 664,
592, 546, 507 cm−1. Anal. Calcd for C25H34N2O4SSi: C, 61.69; H,
7.04; N, 5.76. Found: C, 61.66; H, 7.16; N, 5.61.
1
3h: colorless solid; mp 79−82 °C; H NMR (300 MHz, CDCl3)
7.34−7.26 (m, 5 H), 4.91 (t, J = 5.5 Hz, 1 H), 4.57 (s, 2 H), 3.97 (s, 2
H), 3.80 (d, J = 5.7 Hz, 2 H), 3.27 (s, 3 H), 0.88 (s, 9 H), 0.08 (s, 6
H); 13C NMR (75 MHz, CDCl3) 157.5, 149.3, 135.9, 128.8, 127.8,
127.7, 101.4, 52.3, 48.8, 43.4, 39.8, 25.4, 17.9, −4.7; IR (KBr) 3029,
2931, 2858, 1687, 1469, 1427, 1342, 1283, 1247, 1198, 1130, 1097,
1079, 1050, 1008, 965, 934, 886, 843, 777, 737, 698, 639, 590, 556,
515, 490 cm−1; HR-MS (ESI) calcd for C19H30N2O4SSi ([M + Na]+)
433.1588, found 433.1583.
3i: colorless solid; mp 143−144.5 °C; 1H NMR (300 MHz, CDCl3)
7.96 (d, J = 8.3 Hz, 2 H), 7.30 (d, J = 8.1 Hz, 2 H), 7.11 (d, J = 8.1 Hz,
1 H), 6.40 (m, 2 H), 5.66 (m, 1 H), 5.56 (m, 1 H), 4.47 (s, 2 H), 4.02
(m, 2 H), 3.91 (m, 2 H), 3.77 (s, 3 H), 3.73 (s, 3 H), 2.41 (s, 3 H);
13C NMR (75 MHz, CDCl3) 160.6, 158.5, 157.2, 143.9, 136.0, 130.4,
129.3, 128.7, 125.8, 125.2, 116.7, 104.1, 98.4, 55.3, 55.2, 47.2, 46.9,
45.3, 21.6; IR (KBr) 2935, 1695, 1614, 1508, 1465, 1417, 1349, 1290,
1209, 1162, 1124, 1092, 1035, 876, 815, 739, 665, 588, 549 cm−1. Anal.
Calcd for C21H24N2O5S: C, 60.56; H, 5.81; N, 6.73. Found: C, 60.39;
H, 5.91; N, 6.68.
3j: colorless oil; 1H NMR (300 MHz, CDCl3) 7.13 (d, J = 7.9, 1 H)
6.45−6.41 (m, 2 H), 5.69−5.65 (m, 1 H), 5.59−5.56 (m, 1 H), 4.50
(s, 2 H), 4.12 (s, 2 H), 3.90 (s, 2 H), 3.78 (s, 3 H), 3.77 (s, 3 H), 3.24
(s, 3 H); 13C NMR (75 MHz, CDCl3) 160.0, 158.5, 157.7, 130.6,
125.5, 125.2, 116.5, 104.1, 98.4, 55.4, 55.3, 47.5, 46.7, 45.4, 39.7; IR
(KBr) 3628, 2936, 2839, 1696, 1613, 1508, 1340, 1160, 1085, 1035,
966, 878, 835, 761, 735, 703, 645, 568, 535, 512 cm−1; HR-MS (ESI)
calcd for C15H20N2O5S ([M + Na]+) 363.0985, found 363.0974.
3k: colorless solid; mp 147.5−149.8 °C; 1H NMR (300 MHz,
CDCl3) 7.94 (d, J = 8.2 Hz, 2 H), 7.30 (d, J = 8.2 Hz, 2 H), 5.60 (m,
1 H), 3.90 (d, J = 4.3 Hz, 1 H), 3.83 (s, 3 H), 3.30 (t, J = 7.5 Hz, 2 H),
2.41 (s, 3 H), 1.65 (s, 3 H), 1.51−0.84 (m, 7 H); 13C NMR (150
MHz, CDCl3) 156.5, 143.9, 135.8, 134.1, 129.3, 128.7, 119.8, 50.2,
49.1, 45.6, 30.0, 21.6, 21.0, 19.9, 13.8; IR (KBr) 2963, 2859, 1698,
1473, 1340, 1238, 1159, 1103, 1035, 832, 746, 657, 580, 542, 513
cm−1. Anal. Calcd for C17H24N2O3S: C, 60.69; H, 7.19; N, 8.33.
Found: C, 60.55; H, 7.17; N, 8.22.
3b: colorless oil; 1H NMR (300 MHz, CDCl3) 7.34−7.23 (m, 5 H),
5.74−5.71 (m, 1 H), 5.69−5.66 (m, 1 H), 4.57 (s, 2 H), 4.20−4.18
(m, 2 H), 3.88−3.86 (m, 2 H), 3.26 (s, 3 H); 13C NMR(75 MHz,
CDCl3) 158.3, 135.9, 128.8, 127.8, 127.7, 126.0, 124.9, 52.8, 46.7, 45.7,
39.8; IR (KBr) 3626, 3033, 2930, 1691, 1496, 1471, 1421, 1343, 1239,
1159, 1092, 1029, 965, 933, 878, 762, 700, 557, 514, 468 cm−1; HR-
MS (ESI) calcd for C13H16N2O3SNa ([M + Na]+) 303.0774, found
303.0765.
3c: colorless solid; mp 165−166 °C; 1H NMR (300 MHz, CDCl3)
7.99−7.20 (m 9 H), 5.46 (d, J = 1.5 Hz, 1 H), 4.52 (s, 2 H), 3.90 (s, 2
H), 3.82 (d, J = 4.3 Hz, 2 H), 2.42 (s, 3 H), 1.64 (s, 3 H); 13C NMR
(150 MHz, CDCl3) 157.5, 144.1, 136.1, 135.8, 133.9, 129.4, 128.8,
128.7, 127.69, 127.66, 119.6, 52.3, 50.2, 45.1, 21.6, 21.0; IR (KBr)
2913, 1683, 1473, 1449, 1428, 1347, 1231, 1161, 748, 733, 704, 689,
2146
dx.doi.org/10.1021/jo201959a | J. Org. Chem. 2012, 77, 2142−2148